جست‌وجوی استاد و پژوهشگر

• Biomechanics
• Functional Morphology
• Biomimetics
• +۵ مورد دیگر

Stanislav N. Gorb is a Professor and Director at the Department of Functional Morphology and Biomechanics within the Zoological Institute of Kiel University, Germany. He holds a PhD in Zoology and Entomology from the Schmalhausen Institute of Zoology, Ukrainian Academy of Sciences. His career includes postdoctoral positions at the University of Vienna and Friedrich-Schiller-University Jena, followed by leadership roles at Max Planck Institutes in Stuttgart and Tübingen before joining Kiel in 2008. Research focuses on biological surfaces and their mechanical properties, including friction, adhesion, and biomimetic applications. Key areas include insect attachment mechanisms, bioinspired materials, and evolutionary adaptations in animal/plant systems. His work integrates zoology, materials science, and physics, employing advanced microscopy and tribological techniques. Awards: Schlossmann Award (1995), BioFuture Competition (1998), Karl-Ritter-von-Frisch Medal (2018) Memberships: Academy of Science and Literature Mainz (since 2010), National Academy of Sciences Leopoldina (since 2011) Publications exceed 500 peer-reviewed articles, with five patents and authored books. Research tools include AFM, SEM, and computational modeling to study biological systems' functional morphology.

Rolf Müllerمشاهده پروفایل

استاد

• Pharmaceutical Biotechnology
• Natural Products
• Secondary Metabolites
• +۱۱ مورد دیگر

Prof. Dr. Rolf Müller is a Professor of Pharmaceutical Biotechnology at the Helmholtz-Institut für Pharmazeutische Forschung Saarland (HIPS), affiliated with the Faculty of Natural Sciences and Technology. His research group operates within the Department of Pharmaceutical Science, focusing on the discovery and development of biologically active natural products from microorganisms, especially myxobacteria. The core of his research lies in understanding the molecular mechanisms behind the biosynthesis and regulation of secondary metabolites—compounds with significant therapeutic potential as antibiotics, anticancer agents, immunosuppressants, and antidiabetics. His group explores genetic and biochemical pathways involved in natural product formation, contributing to drug discovery and biotechnological innovation. Key research initiatives include participation in the BMBF BioFuture competition, focusing on heterologous expression and modification of biosynthetic pathways, and involvement in the Sorangium Genome Project under the competence network for bacterial genome research relevant to agriculture, environment, and biotechnology. Additionally, the team works on the biotechnological production of bromelain, expanding their impact beyond microbial natural products. Scientific awards and honors are not mentioned in the provided text. Rolf Müller leads an active research group at HIPS, Campus E8.1 in Saarbrücken. While specific details about students or grants are not listed, his research is clearly aligned with industrial and pharmaceutical applications, supported by national research programs. His work integrates genomics, molecular biology, and biotechnology to unlock the pharmaceutical potential of understudied bacterial systems.

Helle D. Ulrichمشاهده پروفایل

استاد

• DNA Repair
• Genome Stability
• Ubiquitin Signaling
• +۳ مورد دیگر

Helle D. Ulrich is a Professor at the Johannes Gutenberg University Mainz (JGU) and Scientific Director at the Institute of Molecular Biology (IMB) since 2013. Her research focuses on regulatory mechanisms ensuring accurate DNA duplication, particularly in response to DNA damage, using posttranslational modifiers like ubiquitin and SUMO. Education : Habilitation in Genetics (2000-2004), University of Marburg; PhD in Chemistry (1992-1996), University of California, Berkeley; Diploma in Biology (1988-1994), University of Göttingen. Research Interests Her lab investigates DNA damage bypass during replication, ubiquitin/SUMO signaling dynamics, and tools for genome-wide analysis. Key areas include: Postreplicative repair territories (PORTs) formation Role of ubiquitin chain linkages in template switching Chromatin’s contribution to genome maintenance Development of GLOE-Seq for mapping single-strand breaks Scientific Awards & Honors ERC Advanced Grant (2013) EMBO Young Investigator Award (2003-2006) BioFuture Award (2001-2006) Election to Leopoldina (2021) Her work combines molecular biology, imaging, and CRISPR-based tools to address DNA replication fidelity and genome stability in yeast and mammalian systems.

Derek Sarovichمشاهده پروفایل

پژوهشگر ارشد

• Antibiotic resistance
• Bacterial pathogenesis
• Molecular epidemiology
• +۶ مورد دیگر

Dr Derek Sarovich is a Senior Research Fellow at the Advance Queensland Centre for Bioinnovation, University of the Sunshine Coast, Queensland, Australia. Joining in mid-2017, he specializes in molecular microbiology and bioinformatics with focus on high-morbidity antibiotic-resistant infections. Education: PhD, Queensland Graduate Certificate in Research Communication, Queensland Bachelor of Science (Honours), Queensland His research bridges clinical microbiology and genomics to combat antibiotic resistance through next-generation sequencing. Key interests include bacterial pathogenesis mechanisms, molecular epidemiology of resistant pathogens, and genomic diagnostics for infections like melioidosis and Staphylococcus aureus. He pioneers translational applications where genomic data directly informs clinical treatment protocols. Scientific Awards: Fellow of the Australian Society for Microbiology (FASM), 2018 Charles Darwin University Vice Chancellor’s Award for Exceptional Performance in Research, 2016 NHMRC Research Excellent Award, 2013 Derek leads multiple nationally funded projects advancing genomic diagnostics: Metagenomics for COPD lung infection diagnosis (Wishlist - Sunshine Coast HHS) Darwin Perspective Melioidosis Study Years 27-31 (NHMRC) Rapid diagnostics for resistant infections (QIMR Berghofer & Waste to Biofutures Fund) Staphylococcus aureus host diversity sequencing (Pathology Queensland) He directs the Pathogen-Omics Lab, collaborating with Sunshine Coast Health Institute clinicians to implement genomic technologies at the patient bedside, with ongoing work focused on making sequencing cost-effective for routine hospital use.